Eran Eden

Eran has been the CEO of MeMed since its inception in 2009, leading it from an idea to rapidly growing company. He has 18 years of combined business and academic experience pioneering the development of cutting-edge multidisciplinary technologies that synergize data-science & machine learning, molecular biology and clinical applications. Eran co-founded several highly funded international consortia the mission of which is to develop, clinically validate and commercialize novel technologies for diagnosing patients with infectious diseases and inflammatory disorders. He holds a B.Sc. in Computer Engineering, B.A. in Biology, and M.Sc. in Computer Science (all Cum Laude) from the Technion, Israel Institute of Technology, and a Ph.D. in Systems Biology from the Weizmann Institute of Science, where he was also a lecturer of Data Mining. Eran is co-author of over 100 granted patents and pending applications and over 25 peer-reviewed publications and is the recipient of multiple awards including the prestigious GE and Science Prize for Promising Life Scientists.